Due to a system-wide technology update, we are experiencing extremely high call volume. We appreciate your patience with our operators during this time. Thank you for choosing Fox Chase Cancer Center.
Cancer Diagnostics and Risk Assessment
Technology Transfer Contacts
- Inna Khartchenko, MS, MBA
Director, Technology Transfer
215-214-3989
[email protected] - Natalia Shalginskikh, PhD
Licensing Associate,
Technology Transfer
267-963-7121
[email protected] - Tatiana Venkova, PhD
Licensing Associate,
Technology Transfer
215-983-0257
[email protected]
(technologies available for licensing)
Note: Links to Patents may require a browser newer than Internet Explorer 9, such as Chrome, Safari, Firefox, Edge, or Internet Explorer 11| TECH ID | TITLE | LEAD INVENTOR | CONTACT |
|---|---|---|---|
|
07-43 |
Biomarkers for Early Pancreatic Cancer Detection and Treatment |
Anthony Yeung |
|
|
256-JT |
Novel Diagnostic and Prognostic Marker for Malignant Mesothelioma |
Joseph Testa |
|
|
305-MC |
Estrogen Metabolite Levels and CYP1B1 Polymorphisms in Lung Cancer Diagnosis, Prognosis, and Risk Assessment |
Margie Clapper |
|
|
312-GE |
Novel Diagnostic Method for Predisposition to Colorectal Cancer |
Greg Enders |
|
|
394-EG |
Novel Biomarkers for Prognosis and Diagnosis of Prostate Cancer Published Application No.WO2017049023A1; Summary Other Patent Applications Pending |
Erica Golemis |
|
|
396-EC |
Novel Biomarker For Risk Assessment And Treatment Evaluation For Cancers With Fibrosis |
Edna Cukierman |
|
|
426-SA |
Methods For Diagnosis And Treatment Of Patients Having Solid Tumors |
Sanjeevani Arora |
|
|
431-WE |
High EGFR Somatic Mutation Frequency Targeting the TK Domain in Colorectal Cancer Patients with Microsatellite Instability (MSI) |
Wafik El-Deiry |
|
|
443-JFB |
Novel Cancer Prognostic based on MHC-I Genotype and Presentability |
Joan Font-Burgada |
|
|
461-PA |
Urinary DNA Detection for Monitoring of Urothelial Cancer |
Philip Abbosh |
|
|
516-ZY |
Applications of exosomes in the diagnosis of brain tumors |
Zeng-Jie Yang |
|
|
522-MC |
Estrogen Metabolite Levels and EGFR Mutations in Lung Cancer Risk Stratification and Treatment |
Margie Clapper |
|
|
534-JR |
The usage of r-HCG and the genomic signature of the breast induced by r-HCG in BRCA 1/2 carriers |
Jose Russo |
|
|
546-JT |
Malignant Mesothelioma Susceptibility as a Result of Germline Gene Alteration: novel prognostic and diagnostic marker for mesothelioma. Patent pending; Summary |
Joseph Testa |
Share
-
Share with Facebook
-
Share with twitter
-
Share with email
-
Print this